US-based Greenlight Guru, a medical device quality management software platform, has partnered with a global provider of laboratory testing and advisory services.
Nelson Labs offers more than 800 tests, employing more than 500 scientists in its 13 global laboratory facilities.
Through this strategic alliance between the two brands, medical device companies gain access to Greenlight Guru’s cloud-based platform bundled with Nelson Labs advisory services package to guide manufacturers with biological evaluation planning and regulatory compliance consulting.
David DeRam, CEO of Greenlight Guru, said: “Our strategic alliance with Nelson Labs allows our customers to gain expert biocompatibility advice for their product design early on. This helps them to mitigate risk by eliminating toxic materials and ensure success by bringing their devices into compliance and to the market faster.
“We continually work to increase value for our customers and adding partners like Nelson Labs to our global ecosystem of industry relationships is a critical component in that initiative.”
Todd Sierer, VP of sales and marketing at Nelson Labs, added: “This alliance provides medical device developers the ability to seamlessly transfer information from their Greenlight Guru MDQMS to help form their risk evaluation, thus accelerating their validation process for new products.
“Nelson Advisory Services team can leverage this consolidated information stream to provide holistic support as Greenlight Guru customers transition from planning to product development and testing.”
UCB and Open Medical partnership will support Fracture Liaison Services
Radar Healthcare announces Aamal Medical partnership
Photodisinfectant: can light curb the antimicrobial resistance crisis?
Video games may help teens discuss mental health
Why it’s time to revisit workplace mental health initiatives and make them work for everyone
Innovations in self-diagnostics technology: Paving the way to a healthier future?
Telehealth solution revolutionising stroke care in Cardiff and Vale UHB
‘I was producing addicts every week’ – the doctor-turned-tech leader taking on the opioid crisis
Novel cell therapy granted FDA approval for use as investigational new drug
Pathpoint eTrauma launches at Medway NHS Foundation Trust
- Opinion3 weeks ago
We need to think differently about EPR deployments and redefine the pre-implementation approach
- News1 week ago
Choosing the right stem cell treatment centre
- Deals4 weeks ago
Greater Manchester Pathology Network works with Clinisys on an integrated, interoperable LIMS service
- Research3 weeks ago
AI algorithm developed to measure muscle development